A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas. Issue 1 (17th July 2020)
- Record Type:
- Journal Article
- Title:
- A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas. Issue 1 (17th July 2020)
- Main Title:
- A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomas
- Authors:
- Yogananda, Chandan Ganesh Bangalore
Shah, Bhavya R
Yu, Frank F
Pinho, Marco C
Nalawade, Sahil S
Murugesan, Gowtham K
Wagner, Benjamin C
Mickey, Bruce
Patel, Toral R
Fei, Baowei
Madhuranthakam, Ananth J
Maldjian, Joseph A - Abstract:
- Abstract: Background: One of the most important recent discoveries in brain glioma biology has been the identification of the isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion status as markers for therapy and prognosis. 1p/19q co-deletion is the defining genomic marker for oligodendrogliomas and confers a better prognosis and treatment response than gliomas without it. Our group has previously developed a highly accurate deep-learning network for determining IDH mutation status using T2-weighted (T2w) MRI only. The purpose of this study was to develop a similar 1p/19q deep-learning classification network. Methods: Multiparametric brain MRI and corresponding genomic information were obtained for 368 subjects from The Cancer Imaging Archive and The Cancer Genome Atlas. 1p/19 co-deletions were present in 130 subjects. Two-hundred and thirty-eight subjects were non-co-deleted. A T2w image-only network (1p/19q-net) was developed to perform 1p/19q co-deletion status classification and simultaneous single-label tumor segmentation using 3D-Dense-UNets. Three-fold cross-validation was performed to generalize the network performance. Receiver operating characteristic analysis was also performed. Dice scores were computed to determine tumor segmentation accuracy. Results: 1p/19q-net demonstrated a mean cross-validation accuracy of 93.46% across the 3 folds (93.4%, 94.35%, and 92.62%, SD = 0.8) in predicting 1p/19q co-deletion status with a sensitivity and specificity ofAbstract: Background: One of the most important recent discoveries in brain glioma biology has been the identification of the isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion status as markers for therapy and prognosis. 1p/19q co-deletion is the defining genomic marker for oligodendrogliomas and confers a better prognosis and treatment response than gliomas without it. Our group has previously developed a highly accurate deep-learning network for determining IDH mutation status using T2-weighted (T2w) MRI only. The purpose of this study was to develop a similar 1p/19q deep-learning classification network. Methods: Multiparametric brain MRI and corresponding genomic information were obtained for 368 subjects from The Cancer Imaging Archive and The Cancer Genome Atlas. 1p/19 co-deletions were present in 130 subjects. Two-hundred and thirty-eight subjects were non-co-deleted. A T2w image-only network (1p/19q-net) was developed to perform 1p/19q co-deletion status classification and simultaneous single-label tumor segmentation using 3D-Dense-UNets. Three-fold cross-validation was performed to generalize the network performance. Receiver operating characteristic analysis was also performed. Dice scores were computed to determine tumor segmentation accuracy. Results: 1p/19q-net demonstrated a mean cross-validation accuracy of 93.46% across the 3 folds (93.4%, 94.35%, and 92.62%, SD = 0.8) in predicting 1p/19q co-deletion status with a sensitivity and specificity of 0.90 ± 0.003 and 0.95 ± 0.01, respectively and a mean area under the curve of 0.95 ± 0.01. The whole tumor segmentation mean Dice score was 0.80 ± 0.007. Conclusion: We demonstrate high 1p/19q co-deletion classification accuracy using only T2w MR images. This represents an important milestone toward using MRI to predict glioma histology, prognosis, and response to treatment. … (more)
- Is Part Of:
- Neuro-oncology advances. Volume 2:Issue 1(2020)
- Journal:
- Neuro-oncology advances
- Issue:
- Volume 2:Issue 1(2020)
- Issue Display:
- Volume 2, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 2
- Issue:
- 1
- Issue Sort Value:
- 2020-0002-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-07-17
- Subjects:
- deep learning -- glioma -- 1p/19 co-deletion
616.99481 - Journal URLs:
- https://academic.oup.com/noa ↗
http://www.oxfordjournals.org/ ↗ - DOI:
- 10.1093/noajnl/vdaa066 ↗
- Languages:
- English
- ISSNs:
- 2632-2498
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15089.xml